[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fFNBYMjhSXOLkCIknkHCBzzpPxpdsHtRY9Xm8scsEx7k":3,"$fN8pUYXJekwEcu9AxFuH_mkXBAWEFxzDE2Z5gOqYuou0":49},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},17385,"galderma-laboratorium-gmbh","Galderma Laboratorium GmbH",null,"DEU","ted-v3","https://ted.europa.eu/de/notice/-/detail/1003-2026","2026-06-11 08:47:03","2026-06-28 04:02:45",3,1,"2026-01-02T00:00:00.000Z",[18,32,42],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":11,"award_notice_type":22,"award_date":8,"publication_date":16,"lot_number":8,"contract_title":23,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":27,"buyer_name":28,"region_code":29,"cpv_code":30,"tender_published_at_utc":31,"tender_deadline_utc":8},32182,25189,"1003-2026","can-standard","Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8, 130c Abs. 1 V SGB V zwischen der IKK classic und der Galderma Laboratorium GmbH zu Nemluvio(R)",0.92,"public","free","Deutschland – Arzneimittel – Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der Novartis Pharma GmbH zu Rhapsido","IKK classic","DE","33600000","2026-05-27T22:00:00.000Z",{"award_id":33,"tender_id":34,"source_name":10,"source_award_id":35,"source_url":36,"award_notice_type":22,"award_date":8,"publication_date":37,"lot_number":8,"contract_title":38,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":39,"buyer_name":40,"region_code":29,"cpv_code":30,"tender_published_at_utc":41,"tender_deadline_utc":8},70537,73338,"391843-2025","https://ted.europa.eu/de/notice/-/detail/391843-2025","2025-06-18T00:00:00.000Z","Nemluvio (Wirkstoff: Nemolizumab), ATC D11AH12","Deutschland – Arzneimittel – Arzneimittelrahmenrabattvertrag gemäß § 130a Abs. 8 bzw. § 130c Absatz 1 des Fünften Sozialgesetzbuchs - Nemluvio (Wirkstoff: Nemolizumab), ATC D11AH12","DAK-Gesundheit","2025-06-17T22:00:00.000Z",{"award_id":43,"tender_id":34,"source_name":10,"source_award_id":35,"source_url":36,"award_notice_type":22,"award_date":8,"publication_date":37,"lot_number":44,"contract_title":45,"winner_name":7,"winner_identifier":46,"winner_country":9,"value_eur":15,"currency":47,"confidence":48,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":39,"buyer_name":40,"region_code":29,"cpv_code":30,"tender_published_at_utc":41,"tender_deadline_utc":8},251322,"LOT-0001","Arzneimittelrahmenrabattvertrag gemäß § 130a Abs. 8 bzw. § 130c Absatz 1 des Fünften Sozialgesetzbuchs (SGB V) - Nemluvio (Wirkstoff: Nemolizumab), ATC D11AH12","HRB 50697","EUR",0.97,{"company_slug":6,"years":50,"award_count":14,"top_buyers":51,"yearly_trend":60},5,[52,56],{"buyer_name":40,"buyer_key":53,"award_count":54,"total_value_eur":15,"share_count":55},"dak-gesundheit",2,0.667,{"buyer_name":28,"buyer_key":57,"award_count":15,"total_value_eur":58,"share_count":59},"ikk-classic",0,0.333,[61,63],{"year":62,"award_count":54},2025,{"year":64,"award_count":15},2026]